Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues - PubMed (original) (raw)
Review
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
G Logroscino et al. J Neurol Neurosurg Psychiatry. 2008 Jan.
Abstract
Amyotrophic lateral sclerosis (ALS) is a relatively rare disease with a reported population incidence of between 1.5 and 2.5 per 100,000 per year. Over the past 10 years, the design of ALS epidemiological studies has evolved to focus on a prospective, population based methodology, employing the El Escorial criteria and multiple sources of data to ensure complete case ascertainment. Five such studies, based in Europe and North America, have been published and show remarkably consistent incidence figures among their respective Caucasian populations. Population based studies have been useful in defining clinical characteristics and prognostic indicators in ALS. However, many epidemiological questions remain that cannot be resolved by any of the existing population based datasets. The working hypotheses is that ALS, like other chronic diseases, is a complex genetic condition, and the relative contributions of individual environmental and genetic factors are likely to be relatively small. Larger studies are required to characterise risks and identify subpopulations that might be suitable for further study. This current paper outlines the contribution of the various population based registers, identifies the limitations of the existing datasets and proposes a mechanism to improve the future design and output of descriptive epidemiological studies.
Similar articles
- Incidence of amyotrophic lateral sclerosis in Rhineland-Palatinate, Germany.
Wolf J, Wöhrle JC, Palm F, Nix WA, Maschke M, Safer A, Becher H, Grau AJ. Wolf J, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):269-74. doi: 10.3109/21678421.2014.887733. Epub 2014 Feb 26. Amyotroph Lateral Scler Frontotemporal Degener. 2014. PMID: 24571628 - Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, Muravov O, Horton K; Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia; Centers for Disease Control and Prevention (CDC). Mehta P, et al. MMWR Suppl. 2014 Jul 25;63(7):1-14. MMWR Suppl. 2014. PMID: 25054277 - Clinical epidemiology of ALS in Liguria, Italy.
Bandettini di Poggio M, Sormani MP, Truffelli R, Mandich P, Origone P, Verdiani S, Mantero V, Scialò C, Schenone A, Mancardi GL, Caponnetto C; LIGALS. Bandettini di Poggio M, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Jan;14(1):52-7. doi: 10.3109/17482968.2012.729062. Epub 2012 Oct 3. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23030513 - Epidemiology of amyotrophic lateral sclerosis: A review of literature.
Couratier P, Corcia P, Lautrette G, Nicol M, Preux PM, Marin B. Couratier P, et al. Rev Neurol (Paris). 2016 Jan;172(1):37-45. doi: 10.1016/j.neurol.2015.11.002. Epub 2015 Dec 22. Rev Neurol (Paris). 2016. PMID: 26727307 Review. - Clinical epidemiology of amyotrophic lateral sclerosis.
Brooks BR. Brooks BR. Neurol Clin. 1996 May;14(2):399-420. doi: 10.1016/s0733-8619(05)70264-4. Neurol Clin. 1996. PMID: 8827179 Review.
Cited by
- Update on recent advances in amyotrophic lateral sclerosis.
Riva N, Domi T, Pozzi L, Lunetta C, Schito P, Spinelli EG, Cabras S, Matteoni E, Consonni M, Bella ED, Agosta F, Filippi M, Calvo A, Quattrini A. Riva N, et al. J Neurol. 2024 Jul;271(7):4693-4723. doi: 10.1007/s00415-024-12435-9. Epub 2024 May 27. J Neurol. 2024. PMID: 38802624 Free PMC article. Review. - Non-motor symptoms in motor neuron disease: prevalence, assessment and impact.
Beswick E, Forbes D, Johnson M, Newton J, Dakin R, Glasmcher S, Abrahams S, Carson A, Chandran S, Pal S. Beswick E, et al. Brain Commun. 2023 Dec 7;6(1):fcad336. doi: 10.1093/braincomms/fcad336. eCollection 2024. Brain Commun. 2023. PMID: 38162906 Free PMC article. - The complexity of multidisciplinary respiratory care in amyotrophic lateral sclerosis.
Berlowitz DJ, Mathers S, Hutchinson K, Hogden A, Carey KA, Graco M, Whelan BM, Charania S, Steyn F, Allcroft P, Crook A, Sheers NL. Berlowitz DJ, et al. Breathe (Sheff). 2023 Sep;19(3):220269. doi: 10.1183/20734735.0269-2022. Epub 2023 Oct 10. Breathe (Sheff). 2023. PMID: 37830099 Free PMC article. Review. - Digital health solution for monitoring and surveillance of Amyotrophic Lateral Sclerosis in Brazil.
Barbalho IMP, Fonseca ALA, Fernandes F, Henriques J, Gil P, Nagem D, Lindquist R, Lima T, Dos Santos JPQ, Paiva J, Morais AHF, Dourado Júnior MET, Valentim RAM. Barbalho IMP, et al. Front Public Health. 2023 Aug 25;11:1209633. doi: 10.3389/fpubh.2023.1209633. eCollection 2023. Front Public Health. 2023. PMID: 37693725 Free PMC article. - Repetitive nerve stimulation on survival in amyotrophic lateral sclerosis.
Zhu Y, Bai J, Li M, Wang H, Wang J, Huang X. Zhu Y, et al. Front Neurol. 2023 Aug 16;14:1244385. doi: 10.3389/fneur.2023.1244385. eCollection 2023. Front Neurol. 2023. PMID: 37662046 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous